Sabater, Alfonso L.
Mousa, Hazem M.
Quinones, Xavier
Valenzuela, Felipe
Sanchez Avila, Ronald Mauricio
Orive, Gorka
Anitua, Eduardo
Merayo, Jesús
Perez, Victor L.
Article History
Received: 15 December 2020
Accepted: 6 March 2021
First Online: 21 March 2021
Declarations
:
: Eduardo Anitua is the Scientific Director of BTI Biotechnology Institute. Gorka Orive is a scientist at BTI Biotechnology Institute, a dental company that investigates PRGF-Endoret technology and oral implantology. The rest of the authors declare that there is no conflict of interest regarding the publication of this paper.
: Informed consent for participation was obtained from all participants included in the study.